Los puntos clave no están disponibles para este artículo en este momento.
Significant changes in NO, SDMA, ADMA, and L-arginine levels in schizophrenia and bipolar disorder patients suggest that NO and inhibitors of NO might be implicated in the neurobiology of schizophrenia and bipolar disorder.
Üstündağ et al. (Wed,) studied this question.